IONQ
IONQ
$36.44
+1.87%
IonQ, Inc. is a pioneer in quantum computing, offering access to its trapped-ion quantum computers via cloud platforms and consulting services for algorithm co-development. As a pure-play quantum computing leader, it differentiates itself through its proprietary trapped-ion technology and quantum-computing-as-a-service (QCaaS) model. The current investor narrative centers on the company's path to commercial viability amid a 40% stock decline from all-time highs, with debates around government funding catalysts, insider selling, and the need for additional capital to sustain operations through 2028.…
IONQ
IONQ
$36.44
Related headlines
Investment Opinion: Should I buy IONQ Today?
Rating: Hold. IonQ is a speculative quantum computing pure-play with significant upside potential but equally large risks. The consensus analyst rating is Strong Buy with an average target of $69.11, implying 110% upside, but this optimism must be weighed against extreme valuation and cash burn. For aggressive investors with a high risk tolerance, a small position could be warranted, but for most, the risk/reward is unattractive at current levels.
Supporting evidence: The trailing PS of 96.8x is among the highest in the market, though the forward PS of 9.7x suggests the market expects massive revenue growth to $1.29 billion. Revenue grew 7.5x year-over-year to $64.7 million in Q1 2026, but sequential growth slowed to 4.5%. Gross margins improved dramatically from -43.7% to 23.8%, indicating operational progress. However, the company remains unprofitable with a net loss of $805 million in Q1 2026 (including non-cash gains), and free cash flow is deeply negative at -$424.8 million TTM. The analyst target upside of 110% is enticing, but the wide range ($44.78 to $100) reflects high uncertainty.
Risks & Conditions: The biggest risks are dilution from continued equity issuance, failure to achieve revenue growth expectations, and competitive pressure from Quantinuum and others. This Hold would upgrade to Buy if the stock falls below $25 (near the 52-week low) or if the company announces a clear path to positive free cash flow. It would downgrade to Sell if revenue growth decelerates below 20% year-over-year or if insider selling accelerates. Overall, IonQ appears overvalued relative to its current financials, but the premium may be justified by the long-term quantum opportunity. Investors should only consider this as a high-risk speculative allocation.
Sign up to view all
IONQ 12-Month Price Forecast
The AI assessment is bearish with medium confidence. While the long-term quantum computing opportunity is real, IonQ's current valuation and financial trajectory are not aligned. The trailing PS of 96.8x implies expectations of near-perfect execution, but the company is burning cash at an alarming rate and insiders are selling aggressively. The base case of $69.11 seems optimistic given the technical downtrend and competitive threats. A downgrade to a more bearish stance would occur if revenue growth falls below 50% year-over-year or if the company announces a dilutive offering. An upgrade to neutral would require a significant pullback to below $25 or a clear catalyst like a major government contract.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IONQ's 12-month outlook, with a consensus price target around $68.41 and implied upside of +87.7% versus the current price.
Average Target
$68.41
0 analysts
Implied Upside
+87.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$45 - $100
Analyst target range
IonQ is covered by 12 analysts, with a consensus recommendation of 'Strong Buy' (mean rating 1.42 on a 1-5 scale). The average target price is $69.11, implying an upside of 110.4% from the current price of $32.84. The distribution shows 0 holds and 0 sells, indicating unanimous bullish sentiment among analysts, though this may reflect optimism about the quantum sector rather than near-term fundamentals.
The target range spans from $44.78 (low) to $100.00 (high), representing a wide spread that signals high uncertainty. The high target of $100 assumes successful commercialization and multiple expansion, while the low target of $44.78 still implies 36% upside, suggesting even the most bearish analyst sees value. Recent ratings have been stable, with no downgrades in the past year, but the lack of negative views may also reflect limited sell-side scrutiny. The wide range and small coverage base imply that investors should treat consensus targets with caution, as the stock remains highly speculative.
Bulls vs Bears: IONQ Investment Factors
IonQ presents a classic high-risk, high-reward speculative investment. The bull case rests on unanimous analyst optimism, improving gross margins, strong liquidity, and government funding catalysts that could accelerate commercialization. However, the bear case is equally compelling: massive cash burn leading to dilution, extreme valuation multiples, persistent operating losses, and insider selling that undermines confidence. The single most important tension is whether revenue growth can accelerate enough to justify the forward PS multiple of 9.7x — if growth disappoints, the stock could re-rate significantly lower. Currently, the bearish evidence (cash burn, valuation, insider selling) appears stronger than the bullish narrative, making this a high-risk proposition.
Bullish
- Unanimous Strong Buy Consensus: All 12 analysts rate IonQ a Strong Buy, with a mean recommendation of 1.42 on a 1-5 scale. The average price target of $69.11 implies 110.4% upside from the current $32.84, and even the low target of $44.78 suggests 36% upside.
- Improving Gross Margins: Gross margin improved from -43.7% in Q1 2025 to 23.8% in Q1 2026, demonstrating progress toward unit profitability. This 67.5 percentage point swing indicates the QCaaS model is gaining operating leverage.
- Strong Liquidity and Low Debt: IonQ has a current ratio of 15.5 and debt-to-equity of just 0.008, indicating minimal financial leverage. The balance sheet can support continued R&D investment without near-term solvency risk.
- Government Funding Catalyst: Recent news highlights a $2 billion federal quantum computing funding announcement and direct government equity stakes, providing a sovereign-backed capital runway. This reduces dilution risk and validates the sector.
Bearish
- Massive Cash Burn and Dilution: Free cash flow was -$159.4 million in Q1 2026, with TTM FCF of -$424.8 million. The company issued $1.95 billion in common stock in Q4 2025 alone, heavily diluting existing shareholders.
- Extreme Valuation Premium: Trailing PS ratio of 96.8x is astronomically high compared to any mature hardware company. Even the forward PS of 9.7x, based on optimistic revenue estimates of $1.29 billion, leaves no room for error.
- Insider Selling Red Flag: Insiders have sold $857 million in stock over two years with virtually no buying, as reported in recent news. This signals a lack of confidence from those closest to the business.
- Operating Losses Persist: Operating margin was -419.8% in Q1 2026, with operating income of -$271.5 million. Despite revenue growth, the company remains deeply unprofitable on an operating basis.
IONQ Technical Analysis
IonQ is in a sustained downtrend, with the stock down 25.2% over the past year and currently trading at $32.84, just 38.8% of its 52-week range (low $25.89, high $84.64). The price sits near the lower end of the range, suggesting bearish momentum and potential value trap territory, as the stock has lost over 60% from its 52-week high. The 1-year relative strength vs. SPY is -41.7%, indicating significant underperformance relative to the broad market.
Short-term momentum is sharply negative, with a 1-month price change of -38.7% and a 3-month change of -23.1%, both accelerating the longer-term decline. The 1-month relative strength of -39.5% versus SPY confirms extreme weakness, diverging from the market's positive 1-month return of 0.78%. This divergence signals a potential capitulation or further downside risk, as the stock fails to participate in any market rally.
The 52-week low of $25.89 provides key support; a breakdown below this level could trigger further selling toward the next psychological level. Resistance is at the 52-week high of $84.64, and a move above $50 would be needed to suggest a trend reversal. With a beta of 3.23, IonQ is 223% more volatile than the S&P 500, amplifying both upside and downside moves, which demands strict risk management.
Beta
3.23
3.23x market volatility
Max Drawdown
-67.6%
Largest decline past year
52-Week Range
$26-$85
Price range past year
Annual Return
-8.6%
Cumulative gain past year
| Period | IONQ Return | S&P 500 |
|---|---|---|
| 1m | -29.1% | +0.2% |
| 3m | -21.1% | +3.7% |
| 6m | -8.9% | +8.0% |
| 1y | -8.6% | +18.2% |
| ytd | -22.1% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IONQ Fundamental Analysis
Revenue has grown rapidly, from $7.6 million in Q1 2025 to $64.7 million in Q1 2026, representing a YoY growth of 7.5% (though the base was $60.2 million in Q1 2025). However, sequential growth from Q4 2025's $61.9 million was modest at 4.5%, suggesting a deceleration. The company's QCaaS model is driving top-line expansion, but the absolute revenue base remains small relative to the market cap, and growth is not yet accelerating.
IonQ is unprofitable on a GAAP basis, with a net loss of $805 million in Q1 2026, though this includes a large non-cash gain from fair value adjustments. Operating income was -$271.5 million, and the operating margin was -419.8%, reflecting heavy R&D ($125.7 million) and SG&A ($118.1 million) spending. Gross margin improved to 23.8% in Q1 2026 from -43.7% in Q1 2025, indicating progress toward unit profitability, but the company remains far from positive net income.
The balance sheet shows minimal debt (debt-to-equity of 0.008) and a current ratio of 15.5, indicating strong liquidity. However, free cash flow was -$159.4 million in Q1 2026, and the TTM FCF is -$424.8 million. The company relies on equity issuance and government funding to finance operations, as seen in the $1.95 billion in common stock issued in Q4 2025. ROE is -13.4%, reflecting persistent losses, and the negative FCF yield of -44.4x underscores cash burn concerns.
Quarterly Revenue
$64668000.0B
2026-03
Revenue YoY Growth
+754.7%
YoY Comparison
Gross Margin
23.8%
Latest Quarter
Free Cash Flow
$-424755000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IONQ Overvalued?
Since net income is negative, the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 96.8x, while the forward PS ratio (based on estimated revenue of $1.29 billion) is approximately 9.7x, implying the market expects massive revenue growth. The wide gap between trailing and forward PS suggests aggressive growth expectations are priced in, but the forward multiple still reflects a premium valuation.
Compared to the industry average (not provided, but typically single-digit PS for hardware), IonQ trades at a significant premium. Its PS of 96.8x is far above any mature hardware company, reflecting its status as a high-growth speculative stock. The EV/Sales multiple of 57.3x further confirms the premium, which may be justified by the potential of quantum computing but leaves little room for execution missteps.
Historically, IonQ's PS ratio has ranged from extreme levels (e.g., 8,591x in Q3 2021) to current levels near 97x. The current PS is near the lower end of its historical range, suggesting the stock has de-rated significantly from its peak euphoria. However, it remains elevated relative to fundamentals, and further compression could occur if growth disappoints or cash burn accelerates.
PE
-24.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-24.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IonQ's primary financial risk is its unsustainable cash burn rate. With TTM free cash flow of -$424.8 million and only $64.7 million in quarterly revenue, the company relies heavily on equity issuance and government funding to survive. The $1.95 billion stock issuance in Q4 2025 highlights severe dilution risk, and the negative FCF yield of -44.4x means the company is burning cash at a rate far exceeding its market cap. Operating losses are deep, with an operating margin of -419.8% in Q1 2026, and while gross margins are improving, the path to positive net income remains distant. Revenue concentration in the QCaaS model also poses risk if customer adoption slows.
Market & Competitive Risks: IonQ trades at a trailing PS of 96.8x, a massive premium to any hardware peer, making it vulnerable to valuation compression if growth decelerates. The stock's beta of 3.23 implies 223% more volatility than the S&P 500, amplifying downside in market selloffs. Competitive threats are intensifying: Quantinuum's landmark IPO introduces a well-capitalized rival that could cannibalize market share, while IBM and other tech giants also pursue quantum computing. Regulatory risk is low, but the sector's dependence on government funding creates policy uncertainty. Recent insider selling of $857 million over two years is a major red flag, signaling that those closest to the company see limited upside.
Worst-Case Scenario: In a severe downturn, IonQ could face a funding crisis if equity markets close and government support wanes. Operating losses would force further dilution or a distressed financing, crushing the stock. The realistic downside is to the 52-week low of $25.89, representing a -21.2% decline from the current price of $32.84. However, if the company fails to secure additional funding or revenue growth stalls, the stock could fall below that level, potentially testing $20 or lower — a -39% loss from current levels. The historical max drawdown of -67.6% from the all-time high of $84.64 illustrates the potential for severe losses in this highly speculative name.
FAQ
The key risks are: 1) Financial: Cash burn of -$424.8 million TTM requires constant funding, leading to dilution. The company issued $1.95 billion in stock in Q4 2025. 2) Valuation: Trailing PS of 96.8x leaves no room for error; a growth miss could trigger a severe re-rating. 3) Competitive: Quantinuum's IPO and IBM's quantum efforts could erode IonQ's market share. 4) Insider selling: $857 million sold over two years with no buying is a major red flag. The most severe risk is a funding crisis if equity markets close, potentially driving the stock below $20.
The 12-month forecast is highly uncertain. The bull case (25% probability) sees the stock reaching $69-$100, driven by government contracts and commercial adoption. The base case (50% probability) targets $44.78-$69.11, assuming steady growth in line with analyst estimates. The bear case (25% probability) sees the stock falling to $25.89-$44.78 if growth disappoints or cash burn worsens. The most likely scenario is the base case, which assumes revenue grows to $1.29 billion and gross margins improve, but the stock remains volatile. Investors should monitor quarterly earnings for signs of acceleration or deceleration.
IonQ is overvalued based on traditional metrics. The trailing PS of 96.8x is astronomically high compared to any mature hardware company, which typically trade at single-digit PS multiples. The forward PS of 9.7x, based on estimated revenue of $1.29 billion, is still a premium that implies massive growth. Compared to its own history, the current PS is near the lower end of its range (which peaked at 8,591x in 2021), suggesting the stock has de-rated significantly. However, the valuation still prices in near-perfect execution. The market is paying a premium for the quantum computing opportunity, but any growth disappointment could lead to further multiple compression.
IonQ is a high-risk, high-reward speculative stock. The analyst consensus is Strong Buy with an average target of $69.11, implying 110% upside from $32.84, but the stock has significant risks. The trailing PS of 96.8x is extreme, and the company burns $424.8 million in free cash flow annually. It could be a good buy for aggressive investors who believe in quantum computing's long-term potential and can tolerate a potential 50%+ drawdown. However, for most investors, the risk/reward is unfavorable given the cash burn, dilution, and insider selling. A better entry point might be near the 52-week low of $25.89, where downside is more limited.
IonQ is better suited for long-term investment (3-5 years) given its early stage and high volatility. The stock has a beta of 3.23, meaning it moves 3x the market, making it risky for short-term trading. Short-term traders may profit from momentum swings, but the 38.7% monthly decline shows the downside risk. Long-term investors should be prepared for a potential 50%+ drawdown and hold through volatility. The company has no dividend and negative earnings, so it is purely a growth story. A minimum holding period of 3 years is recommended to allow the quantum computing thesis to play out.